What Fast Tracking the COVID-19 Vaccine Means for the Future of Biopharmaceuticals

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

The world’s largest trade association, Biotechnology Innovation Organization (BIO) represents over 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations spanning the United States and more than 30 other nations. A proactive voice of science and for science that will drive a “bio revolution”, BIO is committed to speaking up for the millions of families around the globe who depend upon their success, driving a revolution that aims to cure patients, protect our climate, and nourishes humanity by:

  • Uniting and empowering biotech innovators and their ecosystem to improve lives
  • Removing barriers to innovation
  • Championing broad access to biotech breakthroughs and scientific equality
  • Catalyzing resilient and sustainable bio-based economies

Dr. Jeremy Levin, Chairman & CEO of Ovid Therapeutics Inc., and BIO’s Executive Committee Board Chair, joins Kevin Stevenson, host of MarketScale’s I Don’t Care podcast, to discuss his company, which concentrates on discovering cures for rare diseases of the brain, why the primary focus of his career has been on finding medicines, and BIO’s role in the development of a COVID-19 vaccine.

“I joined BIO with the idea that new medicines are important to people—they’re important to you, important to me. I wanted us to put the track of the industry only on finding new medicines to cure diseases. When COVID hit, the biotech industry stepped forward,” stated Levin. “This is not one company—this is multiples companies. This is not one approach to vaccines—there are at least six different approaches. This is not simply companies making products—you’ve got to have a safe drug and an effective drug. And we have one arbiter for that, and I am proud to work with them every day of the week—that’s the FDA.”

Listen to Previous Episodes of MarketScale’s I Don’t Care Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

Fiber Deployment
Connected America 2025: Smarter Planning and Partnerships Key to Maximizing Fiber’s Federal Funding and Impact
March 31, 2025

As the digital divide accelerates and fiber deployment sees growth, Connected America 2025 has emerged as a pivotal moment for infrastructure professionals. With over $42.5 billion earmarked through federal programs like the Broadband Equity, Access, and Deployment (BEAD) initiative, the U.S. is undergoing one of the most aggressive broadband expansion efforts in its history….

Read More
Workplace safety
Building a Skilled Trades Workforce: Certifications, Simulation-Based Training & Reskilling with SkillCat
March 31, 2025

Industries across the United States are facing an unprecedented shortage of a skilled trades workforce. With millions of baby boomers retiring and fewer young people entering the trades, sectors like HVAC, manufacturing, and construction are grappling with a critical need for talent. This labor shortage is further compounded by a lack of awareness and…

Read More
K-12 school
Tackling All That K-12 Schools Try to Do: The Solutions
March 31, 2025

As public confidence in major institutions continues to erode, the American K–12 education system finds itself straining under the weight of legacy expectations and modern demands. From grading and college recommendations to extracurriculars and character development, K-12 schools are tasked with a near-impossible mission: to do it all, for everyone. At the same time,…

Read More
wellness
The Rise of AI-Powered Wellness: Vitaquest Taps Big Data to Deliver Personalized Nutrition at Scale
March 31, 2025

The wellness industry is at an inflection point. What once centered around pill packs and generic supplement regimens is now being transformed by an ecosystem of personalization, flavor innovation, and data-driven development. According to research, the global nutraceuticals market is on track to surpass $919 billion by 2030—and with consumer demand increasingly favoring tailored,…

Read More